From baby blood to breakthrough cures — we explore how unlocking fetal hemoglobin through gene editing (exa-cel/Casgevy) is transforming treatment for sickle cell disease and β-thalassemia. 🧬✂️
Featuring the science of BCL11A, CRISPR therapies, and what the future holds for global access 🌍💉
🎧 Tune in: "Switching Gears: From Fetal Hemoglobin to Gene Therapy"
#GeneTherapy #CRISPR #HbF #BCL11A #Casgevy #SickleCell #Thalassemia #Innovation #PrecisionMedicine
